Status:
RECRUITING
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Lead Sponsor:
Children's National Research Institute
Conditions:
Juvenile Idiopathic Arthritis
Systemic Lupus Erythematosus
Eligibility:
All Genders
5-21 years
Brief Summary
The overarching goal of this study is the development of a physiologic endpoint of pain and treatment effect in three distinct rheumatology populations. This would enable objective assessment of pain ...
Eligibility Criteria
Inclusion
- In order to be eligible for inclusion in the study, an individual must meet all of the following criteria:
- Male or female ≥ 5 years of age at screening.
- Documentation of a JIA, SLE or FM diagnosis as evidenced by history
Exclusion
- Any individual who meets any of the following criteria will be excluded from participation in this study:
- • Documented history of eye disease precluding pupillometry
Key Trial Info
Start Date :
July 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04833465
Start Date
July 16 2021
End Date
December 1 2025
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Health System
Washington D.C., District of Columbia, United States, 20010